Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00815334

Enrollment

Registered

2008-12-30

Start date

2008-10-31

Completion date

2008-12-31

Last updated

2009-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vesicoureteral Reflux

Keywords

vesicoureteral reflux, low compliant bladder

Brief summary

Endoscopic subureteral injection for vesicoureteral reflux has become an established alternative to ureter reimplantation in children. Some recent studies suggest that ESI can be also a primary treatment option for VUR in adults. However, the experience with ESI in adults who have VUR associated with decreased bladder compliance is limited. We evaluated the efficacy of endoscopic subureteral injection treatment for vesicoureteral reflux in adults with decreased bladder compliance.

Interventions

PROCEDUREEndoscopic subureteric injection

Endoscopic subureteric injection for the treatment of vesicoureteral reflux using variable materials (polydimethylsiloxane, collagen, and dextranomer/hyaluronic acid copolymer)

Study design

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Who is aged 18 and greater * Who underwent endoscopic subureteral injection for vesicoureteral reflux

Exclusion criteria

* Medical records of whom is not evaluabe

Design outcomes

Primary

Measure	Time frame
Cure rate	3, 12 months

Secondary

Measure	Time frame
adverse events	3, 12 months
predictive factor for cure	3, 12 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026